China VBP Program: Redefining Medtech Go-To-Market Models

As China's tech sector faced sweeping regulatory disruptions that wiped out valuations overnight, its medtech industry began experiencing equally profound policy shifts. The China VBP Program, initially piloted for pharmaceuticals and later extended to medical devices, compels manufacturers to compete on the lowest price for entire market volumes. For more info: https://www.zs.com/insights/medtech-volume-based-procurement-in-china

China VBP Program: Redefining Medtech Go-To-Market Models As China's tech sector faced sweeping regulatory disruptions that wiped out valuations overnight, its medtech industry began experiencing equally profound policy shifts. The China VBP Program, initially piloted for pharmaceuticals and later extended to medical devices, compels manufacturers to compete on the lowest price for entire market volumes. For more info: https://www.zs.com/insights/medtech-volume-based-procurement-in-china
0 Reacties 0 aandelen 6 Views 0 voorbeeld